Are all human-derived follicle-stimulating hormone products the same? A systematic review and meta-analysis using direct and adjusted indirect analyses, to determine whether Fostimon^® is more efficient than Metrodin-HP^®

References

• Keck C , Bassett R , Ludwig M . Factors influencing response, ovarian stimulation. Reprod Biomed Online 2005;11:562–569.
   PubMed Web of Science ®Google Scholar
• Andersen CY , Westergaard LG , van Wely M . FSH isoform composition of commercial gonadotrophin preparations: a neglected aspect? Reprod Biomed Online 2004;9:231–236.
   PubMed Web of Science ®Google Scholar
• Bassett RM , Driebergen R . Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH. Reprod Biomed Online 2005;10:169–177.
   PubMed Web of Science ®Google Scholar
• Baker VL , Fujimoto VY , Kettel LM , Adamson GD , Hoehler F , Jones CE , Soules MR . Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial. Fertil Steril 2009;91:1005–1011.
   PubMed Web of Science ®Google Scholar
• Moustafa M , Abdelwahed A , Abosekena I , Abdelazim S , Abou-Setta A , Al-Inany H . IVF outcomes with either highly purified FSH vs. recombinant FSH in down-regulated normogonadotrophic women: a prospective comparative study in a developing country and metaanalysis. Open Women Health J 2009;3:11–15.
   Google Scholar
• Higgins J , Green S . El-Danasouri I . Cochrane handbook for systematic reviews of interventions version 5.0.1: the cochrane collaboration. 2008.
   Google Scholar
• Moher D , Liberati A , Tetzlaff J , Altman DG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Song F , Altman DG , Glenny AM , Deeks JJ . Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003;326:472.
   PubMed Web of Science ®Google Scholar
• Petitti DB . Approaches, heterogeneity in meta-analysis. Stat Med 2001;20:3625–3633.
   PubMed Web of Science ®Google Scholar
• Higgins JPT , Green S (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org
   Google Scholar
• Berger E , Chabloz P , De Quay N , Sann A , Walton S , Germond M , Birkhauser M . An open, randomized, group-comparative bicentre study comparing recombinant FSH Follitropinum B 150 IU and highly purified urinary FSH 225 IV as a fixed dose regimen in IVF/lCSI treatment [abstract]. Hum Reprod 1999;14:61–62.
   Web of Science ®Google Scholar
• Cheon KW , Byun HK , Yang KM , Song IO , Choi KH , Yoo KJ . Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques. J Reprod Med 2004;49:733–738.
   PubMed Web of Science ®Google Scholar
• Machado MG , Borges de Souza MC , Oliveira JBA , Henriques CA , Mancebo ACA . Highly purified gonadotropin and recombinant gonadotropin: study in IVF cycles. Gynecol Endocrinol 1999;37 (suppl 13): Abstract FC-51.
   Google Scholar
• Ulug U , Bahceci M . Efficacy of urinary follicle-stimulating hormone (FSH) among poor responders. ClinicalTrialsgov, 2009: NCT00677573. Available online at: www.clinicaltrials.gov
   Google Scholar
• Anserini P , Costa M , Remorgida V , Venturini PL . A prospective, randomized, controlled clinical study of a new subcutaneous, purified, urinary FSH preparation for controlled ovarian hyperstimulation in in vitro fertilization. Gynecol Endocrinol 2000;14:75–80.
   PubMed Web of Science ®Google Scholar
• Gerli S , Perino M , Abate A , Costabile L , Gholami H , Vitiello L . Ovarian stimulation using a new highly purified urinary FSH: a prospective randomized clinical study. Clin Exp Obstet Gynecol 1999;26:93–94.
   PubMedGoogle Scholar
• Aboulghar M , Saber W , Amin Y , Mansour R , Serour G . Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization/intracytoplasmic sperm injection in patients with polycystic ovary syndrome. Fertil Steril.2010;94 (6):2332–2334.
   Google Scholar
• Selman HA , De Santo M , Sterzik K , Coccia E , El-Danasouri I . Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality. Fertil Steril 2002;78:1061–1067.
   PubMed Web of Science ®Google Scholar
• Selman H , Pacchiarotti A , El-Danasouri I . Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome.
   Google Scholar
• Mohamed MA , Sbracia M , Pacchiarotti A , Micara G , Linari A , Tranquilli D , Espinola SM , Aragona C . Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study. Fertil Steril 2006;85:1398–1403.
   PubMed Web of Science ®Google Scholar
• Abate A , Nazzaro A , Salerno A , Marzano F , Pavone Cossut MR , Perino M . Efficacy of recombinant versus human derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: randomised, controlled, multi-centre trial. Gynecol Endocrinol 2009:1–6.
   Web of Science ®Google Scholar
• Aboulghar M , Saber W , Amin Y , Aboulghar M , Mansour R , Serour G . A prospective randomized study comparing highly purified urinary FSH and recombinant FSH for IVF/ICSI in patients with polycystic ovarian syndrome. Cairo: The Egyptian IVF-ET Center 2009.
   Google Scholar
• Grudzinskas G . Recent clinical evidence for selecting u-FSH or rFSH in ART. Fertil Steril 2006;86:S427–S428.
   Web of Science ®Google Scholar
• Bergh C , Howles CM , Borg K , Hamberger L , Josefsson B , Nilsson L , Wikland M . Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133–2139.
   PubMed Web of Science ®Google Scholar
• Ferraretti AP , Gianaroli L , Magli MC , Feliciani E , Gergolet M , Fortini D . Recombinant FSH versus urinary FSH in non-down regulated poorly responding patients. In: 11th world congress of in vitro fertilization and human reproductive genetics 1999. International Society for In Vitro Fertilization.
   Google Scholar
• Franco JG, Jr. , Baruffi RL , Coelho J , Mauri AL , Petersen CG , Garbellini E . A prospective and randomized study of ovarian stimulation for ICSI with recombinant FSH versus highly purified urinary FSH. Gynecol Endocrinol 2000;14:5–10.
   PubMed Web of Science ®Google Scholar
• Frydman R , Howles CM , Truong F . A double-blind, randomized study, compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The french multicentre trialists. Hum Reprod 2000;15:520–525.
   PubMed Web of Science ®Google Scholar
• Germond M , De Palma R , Senn A , Inaudi P , Dessole S , De Grandi P . Recombinant versus highly purified urinary FSH to induce ovulation induction and pregnancies in women over 35 years in an IVF/ICSI programme. Hum Reprod 2000;16: (Abstract book), 46–47.
   Google Scholar
• Ghosh S , Chattopadhyay R , Goswami S , Chakravarty BN . Recombinant FSH versus highly purified urinary FSH – our experience. In: 11th world congress of in vitro fertilization and human reproductive genetics, International Society for In Vitro Fertilization.1999:264.
   Google Scholar
• Hoomans EH , Andersen AN , Loft A , Leerentveld RA , van Kamp AA , Zech H . A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon®) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP®) in a fixed-dose regimen in women undergoing ovarian stimulation. Hum Reprod 1999;14:2442–2447.
   PubMed Web of Science ®Google Scholar
• Hugues JN , Bry-Gauillard H , Bstandig B , Uzan M , Cedrin-Durnerin I . Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryo transfer. J Assist Reprod Genet 2001;18:191–196.
   PubMed Web of Science ®Google Scholar
• Lenton E , Soltan A , Hewitt J , Thomson A , Davies W , Ashraf N , Sharma V , Jenner L , Ledger W , McVeigh E . Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP). Hum Reprod 2000;15:1021–1027.
   PubMed Web of Science ®Google Scholar
• Nardo LG , Bellanca SA , Messina K , Nardo F . Efficacy of recombinant follicle stimulating hormone versus urinary follicle stimulating hormone in in-vitro fertilization: a prospective, randomized, assessor-blind study. Ital J Gynaecol Obstet 2000;12:44–53.
   Google Scholar
• Schats R , Sutter PD , Bassil S , Kremer JA , Tournaye H , Donnez J . Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of the Feronia and Apis study group. Hum Reprod 2000;15:1691–1697.
   PubMed Web of Science ®Google Scholar
• Chen X-N , Lu GX , Yan JM , Chen ZJ , Xiao HM , Chen G . An open, prospective, randomized, multicenter study, compare recombinant human follicle stimulating hormone (rec-FSH; follitropin-beta; Puregon (R) solution) with highly purified urinary FSH (uFSH, urofollitropin (highly purified), Metrodin (R) HP) in Chinese women undergoing in vitro fertilization (IVF). Fertil Steril 2004;82:s228.
   PubMed Web of Science ®Google Scholar
• Daya S . Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertil Steril 2002;77:711–714.
   PubMed Web of Science ®Google Scholar
• Daya S , Gunby J . Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod 1999;14:2207–2215.
   PubMed Web of Science ®Google Scholar
• Bayram N , van Wely M , Van der Veen F . Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. In: Cochrane database of systematic reviews.Chichester, UK: John Wiley & Sons, Ltd 2001.
   Google Scholar
• D'Antonio M , Borrelli F , Datola A , Bucci R , Mascia M , Polletta P , Piscitelli D , Papoian R . Biological characterization of recombinant human follicle stimulating hormone isoforms. Hum Reprod 1999;14:1160–1167.
   PubMed Web of Science ®Google Scholar
• Baird DT . Is there a place for different isoforms of FSH in clinical medicine? IV. The clinician's point of view. Hum Reprod 2001;16:1316–1318.
   PubMed Web of Science ®Google Scholar
• Lambert A , Talbot JA , Anobile CJ , Robertson WR . Gonadotrophin heterogeneity and biopotency: implications for assisted reproduction. Mol Hum Reprod 1998;4:619–629.
   PubMed Web of Science ®Google Scholar
• Nayudu PL , Vitt UA , Barrios De Tomasi J , Pancharatna K , Ulloa-Aguirre A . Intact follicle culture: what it can tell us about the roles of FSH glycoforms during follicle development. Reprod Biomed Online 2002;5:240–253.
   PubMedGoogle Scholar
• McAlister FA , Laupacis A , Wells GA , Sackett DL . Users' Guides, the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effect. JAMA 1999;282:1371–1377.
   PubMed Web of Science ®Google Scholar